False Claims Act Resource Center
 

Archive for the ‘Healthcare’ Category

St. Jude Medical is in Talk to Settle False Claim Case

Tuesday, September 7th, 2010

In 2006, Charles Donigan sued his former employer, St. Jude Medical, under the Federal False Claims Act for allegedly paying kickbacks to physicians and other health care providers to induce them to use St. Jude medical devices, including pacemakers. Four years later, after the government indicated its intent to intervene in the lawsuit, St. Jude is discussing settlement with the government. The allegations center around payments made to physicians for data collection and studies of St. Jude products, which included entertainment, travel and passes to sporting events. It is not clear how much money St. Jude might pay to settle. But, the case is part of a broader investigation of medical device kickbacks in which Boston Scientific recently settled claims for $22 million.

For more information see:  http://online.wsj.com/article/BT-CO-20100826-711507.html

  • Share/Bookmark

Allergan settles Botox Claims for $600 million

Friday, September 3rd, 2010

Allergan settled claims of off-label marketing of its Botox pharmaceutical and other claims for a total of $600 million.  The government accused Allergan of recommending Botox for unapproved uses including headache, pain, spasticity and juvenile cerebral palsy.  As part of the settlement, Allergan also pleaded guilty to misdemeanor charge of misbranding, or inadequate labeling of products for intended uses.  Allergan is also required under the settlement to hire and pay for a third-party to monitor is compliance efforts for the next five years. 

For more information see:  http://online.wsj.com/article/SB10001424052748703882304575465371767239834.html?mod=googlenews_wsj

  • Share/Bookmark

South Florida Health Care Providers Plead Guilty in Medicare Fraud Scheme

Friday, September 3rd, 2010

A physician, clinic owner and a number of clinic nurses pleaded guilty to participating in a large Medicare fraud conspiracy.  Dr. Fred Dweck, Yudel Cayro and others referred numerous Medicare recipients for unnecessary home health care services and charged those services to Medicare. In total, Medicare paid more than $32 million of the $53 million fraudulent claims billed. The clinic owner admitted to receiving kickback from individuals who recruited Medicare recipients, and from owners of Miami home health agencies. Several nurses also pleaded guilty for falsifying patients files of Medicare beneficiaries to make it appear that they qualified for home health care and therapy services. Each of the defendants faces up to 10 years in prison for each conspiracy county to commit health care fraud.

For more information see:  http://www.bizjournals.com/southflorida/stories/2010/08/30/daily16.html

  • Share/Bookmark

Hospital to the Stars to repay Government $5.25 million

Tuesday, August 31st, 2010

St. John’s Medical Center of Santa Monica, California has agreed to repay the federal government $5.25 million to settle claims that it overbilled Medicare.  The government alleged that St. John’s “turbocharged” its claims to Medicare by raising charges more quickly than its actual costs rose.  According to the government, the practice allowed St. John’s to obtain significantly greater outlier payments, which are payments designed to reimburse hospitals for extraordinarily costly care to patients, that it was not entitled to receive.  The payment covers claims made between 1996 and 2009. 

For more information see:  http://www.fiercehealthcare.com/story/medicare-fraud-saint-johns-health-center-pay-5-25m-overbilling/2010-08-26

  • Share/Bookmark

Massachusetts settles with medical device company for “off label” marketing

Tuesday, August 31st, 2010

The Massachusetts Attorney General settled claims of off label marketing with medical device maker, Stryker Biotech.  The state claimed that Stryker violated state consumer protection laws by falsifying documents from Massachusetts hospitals’ Institutional Review Boards in order to obtain get approval for the use of its bone growth products.  Thus, Stryker was alleged to have marketed products that the government had yet to approve.  “Off label” marketing describes the illegal practice of marketing a product for a use that was not approved.  Such “off-label” marketing is misleading to health care providers about the appropriate use of approved products.  Stryker Biotech agreed to pay the state $1.35 million to settle the claims. 

For more information see: http://www.bizjournals.com/boston/stories/2010/08/23/daily27.html?ana=e_du_pub

  • Share/Bookmark

Johnson & Johnson Unit Issued FDA Warning Letter

Friday, August 27th, 2010

On August 19, 2010, the U.S. Food and Drug Administration issued a warning letter to DePuy Orthopaedics, Inc., a business unit of Johnson & Johnson, stating that it is marketing two products without required clearance or approvals in violation of the Federal Food, Drug, and Cosmetic Act. The warning letter was specifically directed at two (2) DePuy Orthopaedics’ products, the TruMatch Personalized Solutions System and the Corail Hip System. The FDA claimed that the TruMatch system did not receive pre-market approval and was misbranded because of the lack of notification to the FDA. Likewise, the Corail Hip System received FDA pre-market notification but was marketed for uses beyond that specific notification. DePuy is required to respond within fifteen (15) days to the FDA’s letter and explain its plan to prevent these violations from occurring in the future and document any corrective action taken.

For more information see: http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm223613.htm

  • Share/Bookmark

Medicare and Medicaid Contractor Settles Claim for $137.5 Million

Wednesday, August 25th, 2010

On August 20, 2010, it was announced that a Medicare and Medicaid managed-care company, WellCare Health Plans, Inc., reached a preliminary settlement to pay $137.5 million to settle a False Claims Act case which has been pending for the past four years.  The allegations arise from claims that WellCare was responsible for schemes to avoid repaying overpayments which it received from Florida and New York’s Medicaid programs, inflate reinsurance payments, and disenroll Medicaid beneficiaries whom the company considered unprofitable.  The False Claims Act complaint also alleged that the company stole $400 million to $600 million from Medicare and Medicaid programs in several states.

This lawsuit was initiated by a former WellCare senior analyst, Sean Hellein, who worked with the Justice Department and wore a hidden wire as part of the undercover investigation into the alleged criminal misconduct by WellCare.  The False Claims Act allows the individual who initiates the lawsuit to share in a portion of the recovery obtained in any lawsuit or settlement.

For more information see:  http://www.ama-assn.org/amednews/2010/08/16/bisg0820.htm

or http://online.wsj.com/article/BT-CO-20100810-713391.html

  • Share/Bookmark

Federal Court Allows Government’s Medicaid Fraud Suit to Move Forward

Wednesday, August 18th, 2010

Late last month, a federal court in Virginia ruled that the government may proceed with a False Claims Act suit against a juvenile psychiatric facility run by subsidiaries of Universal Health Services, Inc.  The suit alleges that the Marion Youth Center, a treatment center for adolescent boys, submitted false claims to Medicaid.  Specifically, the government claims that the defendants falsely represented that they provided inpatient psychiatric services to children covered by Medicaid.  In reality, the government claims that the facility failed to provide psychiatric treatment and instead operated like a detention facility, submitting bills to Medicaid for what amounted to little more than confinement.  The government also alleges that the facility deliberately provoked and taunted children on Medicaid to create a pretext justifying longer stays for the children, thus increasing the Marion Youth Center’s Medicaid billings and payments.

The defendants had moved to dismiss the suit, arguing that the government failed to allege a violation of the False Claims Act, or a similar Virginia anti-fraud law.  The court agreed as to parent company UHS, but held that the case may proceed against two UHS subsidiaries that operate the Marion Youth Center.  The government is now seeking to amend its complaint to add detailed allegations that UHS supervised and controlled operations, including Medicaid billing, at Marion.

For more information see:  http://online.wsj.com/article/BT-CO-20100809-711002.html?mg=com-wsj

  • Share/Bookmark

U.S. to Pursue False Claims Act Kickback Suit Against Pacemaker Manufacturer

Wednesday, August 18th, 2010

Last week, the United States Department of Justice announced that it would intervene in a False Claims Act suit against St. Jude Medical, Inc., alleging that the manufacturer of pacemakers and other heart devices participated in an illegal kickback scheme resulting in the submission of false claims for reimbursement to the government.  The U.S. had previously declined to intervene in December 2009, but now, after reviewing additional documents and interviewing more witnesses, believes it has “good cause to intervene.”

The suit against St. Jude Medical was filed by Charles Donigan, who worked as a technical service specialist for the company from 2004 until 2007.  Donigan’s suit alleged that St. Jude Medical paid kickbacks to doctors, hospitals and other healthcare providers to induce them to prescribe its products.  The providers then submitted claims for reimbursement to Medicare and other federal programs in violation of the False Claims Act, according to Donigan.  The suit also alleges that St. Jude violated a separate anti-kickback law by providing “sham fees” for phony clinical studies, and by providing doctors and their spouses with various lobbyist-like perks, such as vacations, tickets to sporting events, and “educational” programs at luxury resorts.

The government’s decision to intervene comes on the heels of a June settlement with St. Jude in a separate False Claims Act suit, under which the company agreed to pay $3.7 million to settle allegations that it paid illegal kickbacks to Kentucky and Ohio hospitals. 

For more information see:  http://www.reuters.com/article/idUSTRE6755E820100806?type=domesticNews

  • Share/Bookmark

Tenet Healthcare is Focus of Medicare Fraud Probe

Tuesday, August 10th, 2010

Last week, Tenet Healthcare acknowledged, in a regulatory filing, that the United States Department of Justice is investigating whether one of Tenet’s hospitals fraudulently billed Medicare for heart defibrillator implant surgeries.  The D.O.J. probe dates to March 2010, when it issued a demand to Tenet under the False Claims Act seeking information and patient records detailing Tenet’s submissions for implantable heart defibrillator procedures as far back as 2002.  According to Tenet’s filing, the company believes the Justice Department is attempting to determine if the defibrillator procedures followed Medicare coverage requirements.

Implantable defibrillator manufacturers Medtronic and St. Jude Medical, Inc. previously acknowledged receiving similar requests from the Justice Department in March.  Like Medtronic and St. Jude, Tenet said it will cooperate with the government’s investigation.

For more information see:  http://www.reuters.com/article/idUSN0317069820100803

  • Share/Bookmark
 

 
Blog Home   |   Website Home   |   Our Practice   |   State False Claims Acts   |   Common Types of Fraud   |   Contact Us
 
215-320-6200
© 2010 False Claims Act. All rights reserved. | Blog by LISI
Attorney Advertising
The information on this site is not, nor is it intended to be, legal advice. Prior results do not guarantee a similar outcome.